Bone Health

Latest News

European Commission approved biosimilars for bone and eye conditions. | Image credit: Andrzej - stock.adobe.com
EC Approves New Biosimilars for Bone and Eye Conditions

September 19th 2025

The European Commission (EC) approves new biosimilars for osteoporosis and eye conditions, enhancing treatment options and patient access across Europe.

FDA approves denosumab biosimilars | Image Credit: wladimir1804 - stock.adobe.com
FDA Approves Biocon Biologics' Denosumab Biosimilars: Bosaya and Aukelso

September 18th 2025

FDA Approved. | Image Credit: gguy - stock.adobe.com .jpeg
FDA Greenlights Fifth Pair of Denosumab Biosimilars: Bildyos and Bilprevda

September 2nd 2025

Bone metastases. | Image Credit:  Nasr -  stock.adobe.com
Denosumab Biosimilar LY01011 Shows Equivalence to Reference Product for Bone Metastases

August 14th 2025

woman with osteoporosis | Image credit: SoftSheep - stock.adobe.com
Two More Pairs of Denosumab Biosimilars Enter US Market

July 9th 2025

© 2025 MJH Life Sciences

All rights reserved.